S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
The Next Big Crisis Is Here (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
The Next Big Crisis Is Here (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
The Next Big Crisis Is Here (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
The Next Big Crisis Is Here (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
The Next Big Crisis Is Here (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
The Next Big Crisis Is Here (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
The Next Big Crisis Is Here (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
The Next Big Crisis Is Here (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
The Next Big Crisis Is Here (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
The Next Big Crisis Is Here (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
The Next Big Crisis Is Here (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
The Next Big Crisis Is Here (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
NYSE:CNMD

CONMED - CNMD Stock Forecast, Price & News

$93.91
-2.02 (-2.11%)
(As of 01/30/2023 12:00 AM ET)
Add
Compare
Today's Range
$93.84
$96.31
50-Day Range
$79.75
$98.97
52-Week Range
$71.09
$155.51
Volume
273,805 shs
Average Volume
400,011 shs
Market Capitalization
$2.86 billion
P/E Ratio
N/A
Dividend Yield
0.83%
Price Target
$106.00

CONMED MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
12.9% Upside
$106.00 Price Target
Short Interest
Bearish
11.71% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
0.63mentions of CONMED in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$401,895 Sold Last Quarter
Proj. Earnings Growth
6.98%
From $3.15 to $3.37 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

Medical Sector

794th out of 1,055 stocks

Electromedical Equipment Industry

19th out of 23 stocks


CNMD stock logo

About CONMED (NYSE:CNMD) Stock

CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States, Americas excluding the United States, Europe, Middle East, and Africa, and Asia Pacific. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

CNMD Stock News Headlines

CONMED (CNMD) Set to Announce Quarterly Earnings on Thursday
Reviewing CONMED (NYSE:CNMD) & Star Equity (NASDAQ:STRR)
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
CONMED Corp.
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
ConMed: Still Fairly Priced, Turning More Constructive
CONMED Corporation Announces Quarterly Cash Dividend
Why Is Conmed (CNMD) Up 6.8% Since Last Earnings Report?
CONMED Corp. Withdraws Full-year Guidance
See More Headlines
Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

CNMD Company Calendar

Ex-Dividend for 1/5 Dividend
12/15/2022
Dividend Payable
1/05/2023
Today
1/30/2023
Next Earnings (Confirmed)
2/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Employees
3,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$106.00
High Stock Price Forecast
$106.00
Low Stock Price Forecast
$106.00
Forecasted Upside/Downside
+12.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$62.54 million
Pretax Margin
-2.87%

Debt

Sales & Book Value

Annual Sales
$1.01 billion
Cash Flow
$6.16 per share
Book Value
$26.85 per share

Miscellaneous

Free Float
28,988,000
Market Cap
$2.86 billion
Optionable
Optionable
Beta
1.35

Key Executives

  • Curt R. HartmanCurt R. Hartman
    Chairman, President & Chief Executive Officer
  • Todd W. GarnerTodd W. Garner
    Chief Financial Officer & Executive Vice President
  • Shanna L. Cotti-Osmanski
    Chief Information Officer & Executive VP-IT
  • Heather L. Cohen
    EVP, Chief Human Resources & Legal Officer
  • Terence M. Bergé
    Vice President & Controller













CNMD Stock - Frequently Asked Questions

Should I buy or sell CONMED stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CNMD shares.
View CNMD analyst ratings
or view top-rated stocks.

What is CONMED's stock price forecast for 2023?

1 Wall Street research analysts have issued 12-month price targets for CONMED's stock. Their CNMD share price forecasts range from $106.00 to $106.00. On average, they predict the company's share price to reach $106.00 in the next year. This suggests a possible upside of 12.9% from the stock's current price.
View analysts price targets for CNMD
or view top-rated stocks among Wall Street analysts.

How have CNMD shares performed in 2023?

CONMED's stock was trading at $88.64 at the beginning of the year. Since then, CNMD shares have increased by 5.9% and is now trading at $93.91.
View the best growth stocks for 2023 here
.

Are investors shorting CONMED?

CONMED saw a increase in short interest in December. As of December 15th, there was short interest totaling 3,550,000 shares, an increase of 7.3% from the November 30th total of 3,310,000 shares. Based on an average trading volume of 412,700 shares, the days-to-cover ratio is currently 8.6 days.
View CONMED's Short Interest
.

When is CONMED's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our CNMD earnings forecast
.

How can I listen to CONMED's earnings call?

CONMED will be holding an earnings conference call on Thursday, February 2nd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How often does CONMED pay dividends? What is the dividend yield for CONMED?

CONMED announced a quarterly dividend on Monday, December 5th. Shareholders of record on Friday, December 16th will be paid a dividend of $0.20 per share on Thursday, January 5th. This represents a $0.80 annualized dividend and a yield of 0.85%. The ex-dividend date is Thursday, December 15th.
Read our dividend analysis for CNMD
.

Is CONMED a good dividend stock?

CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.83%.
Read our dividend analysis for CNMD.

What guidance has CONMED issued on next quarter's earnings?

CONMED issued an update on its FY 2023 earnings guidance on Thursday, December, 15th. The company provided earnings per share guidance of $3.20-$3.50 for the period, compared to the consensus estimate of $3.39. The company issued revenue guidance of $1.17 billion-$1.23 billion, compared to the consensus revenue estimate of $1.21 billion.

What is CONMED's stock symbol?

CONMED trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNMD."

Who are CONMED's major shareholders?

CONMED's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include New York State Common Retirement Fund (0.98%), Congress Asset Management Co. MA (0.55%), Mountain Pacific Investment Advisers Inc. ID (0.41%), Peregrine Capital Management LLC (0.38%), Moody Aldrich Partners LLC (0.17%) and AMI Asset Management Corp (0.16%).
View institutional ownership trends
.

How do I buy shares of CONMED?

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CONMED's stock price today?

One share of CNMD stock can currently be purchased for approximately $93.91.

How much money does CONMED make?

CONMED (NYSE:CNMD) has a market capitalization of $2.86 billion and generates $1.01 billion in revenue each year. The company earns $62.54 million in net income (profit) each year or ($2.95) on an earnings per share basis.

How many employees does CONMED have?

The company employs 3,800 workers across the globe.

How can I contact CONMED?

CONMED's mailing address is 525 FRENCH ROAD, UTICA NY, 13502. The official website for the company is www.conmed.com. The company can be reached via phone at (727) 392-6464 or via fax at 315-797-0321.

This page (NYSE:CNMD) was last updated on 1/31/2023 by MarketBeat.com Staff